Chosa Oncology AB (FRA:W5L)

Germany · Delayed Price · Currency is EUR

0.0324

-0.0004 (-1.22%)

Last updated: Oct 23, 2026, 8:04 AM CEST

Market Cap	3.05M
Revenue (ttm)	n/a
Net Income	-572.30K
EPS	-0.01
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,500
Open	0.0324
Previous Close	0.0328
Day's Range	0.0324 - 0.0324
52-Week Range	0.0002 - 0.1130
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 10, 2026

About Chosa Oncology AB

Chosa Oncology AB, together with its subsidiaries, engages in developing and commercializing medicines for the treatment of cancer in Sweden and USA. It provides Platin-DRP, a multigene mRNA-based algorithm that predicts a patient’s response to platinum-based chemotherapy; and LiPlaCis, a liposomal formulation of cisplatin, enabling delivery of chemotherapy agent directly to tumor sites. The company was formerly known as Chosa ApS. Chosa Oncology AB was incorporated in 2015 and is based in Malmö, Sweden.

Industry Biological Products, Except Diagnostic Substances

Founded 2015

Country Sweden

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol W5L